Mason Morfit

ValueAct Capital Management LP (ValueAct Capital) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 2000 by Jeffrey Ubben, Peter Kamin and George Hamel. They are a subsidiary of ValueAct Holdings II LP, which is owned by Affiliated Managers Group, Inc. (NYSE: AMG). ValueAct Capital provides discretionary investment advice and management services to private investment funds and certain other investment vehicles.

Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA.

Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.

Advanced Medical Optics, Inc. manufactures intraocular lens and optical medical devices for eye disorders. Its products includes intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. It develops sovereign system, which is equipped with WhiteStar software that uses ultrasound power to dissolve dense cataracts that can develop in the eye, Amadeus microkeratome, a device used during LASIK procedures and Verisyse phakic IOL for treatment of moderate to severe myopia. It was founded in 1976 Santa Ana, CA.

MSD Performance, Inc. Manufactures performance based ignition systems. It offers vehicle integration system for street and racing use. The firm specializes in automotive ignition, electronic fuel injections, vehicle management, and vehicle integration systems. Its product include ignitions, sport compact/import, coils, towing/marine, distributors, DynaForce, spark plug wires, tools, rpm/timing controls, accessories, crank triggers, and atomic EFI. The company was founded in 1970 and is headquartered in El Paso, TX.

Immucor, Inc. develops, manufactures and sells transfusion and transplantation diagnostics products. It engages in the development, manufacture, and sale of products used by hospital blood banks, clinical laboratories, and blood donor centers to detect and identify certain properties of human blood prior to patient transfusion. The company was founded on May 19,1982 and is headquartered in Norcross, GA.